scholarly article | Q13442814 |
P50 | author | Steven Rosenberg | Q2347448 |
Edmund K. Bartlett | Q40584715 | ||
Seth M Steinberg | Q92007107 | ||
Francesco Marincola | Q107723823 | ||
P2093 | author name string | Armando C Filie | |
Donald E White | |||
John R Wunderlich | |||
Udai S Kammula | |||
Andrea Abati | |||
Patricia A Fetsch | |||
Daniel J Stephens | |||
P2860 | cites work | CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. | Q24540429 |
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma | Q24607661 | ||
Human tumor antigens recognized by T lymphocytes | Q24678508 | ||
MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma | Q24685652 | ||
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF | Q28143787 | ||
The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
Natural innate and adaptive immunity to cancer | Q29620313 | ||
AACR centennial series: the biology of cancer metastasis: historical perspective | Q33683443 | ||
Immune surveillance of tumors | Q34579196 | ||
Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis | Q34615993 | ||
Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. | Q36037070 | ||
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting | Q37418530 | ||
Cutaneous melanoma: a model to study cancer metastasis | Q37863622 | ||
Biological heterogeneity of cancer: implication to therapy | Q38031385 | ||
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation | Q39262830 | ||
Tumor heterogeneity and the biology of cancer invasion and metastasis | Q39759977 | ||
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions | Q41097918 | ||
Human tumor antigens recognized by T cells | Q41196996 | ||
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. | Q41200467 | ||
Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin | Q42800037 | ||
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo | Q45309151 | ||
Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration | Q48252479 | ||
Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group | Q49042094 | ||
Metastasis results from preexisting variant cells within a malignant tumor | Q67602509 | ||
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice | Q70935075 | ||
Horizontal gene transfer in glycosyl hydrolases inferred from codon usage in Escherichia coli and Bacillus subtilis | Q72991207 | ||
Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo | Q74185524 | ||
Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma | Q74246345 | ||
Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants | Q74447038 | ||
Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary look | Q77364702 | ||
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases | Q80241859 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2607-2616 | |
P577 | publication date | 2014-03-19 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration | |
P478 | volume | 20 |
Q47614555 | Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. |
Q36863359 | Identification of an Immunogenic Subset of Metastatic Uveal Melanoma |
Q39281286 | Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis |
Q33880126 | Location, location, location: The relationship of anatomic site, antigen expression, and T-cell infiltration in human melanoma metastases |
Q38802594 | Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells |
Q41405130 | Melanoma cells homing to the brain: an in vitro model |
Q35044333 | Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans |
Search more.